home > news > detailed info

Aptar Pharma Co Organizer and Diamond Sponsor of RDD Europe 2019 Conference in Estoril Portugal

Aptar Pharma

Crystal Lake, Illinois, March 21, 2019

Aptar Pharma, the leader in respiratory drug delivery systems, is proud to announce its coorganization and diamond sponsorship of the Respiratory Drug Delivery (RDD®) Europe 2019 scientific conference, connecting pulmonary and nasal drug delivery experts from around the world in Estoril, Portugal from May 7-10, 2019.

One of the largest respiratory health conferences worldwide, RDD Europe 2019 is a premium, interactive three-day conference offering a prestigious program that includes a plenary lecture and seven plenary sessions hosted by industry experts - including a U.S. FDA speaker - who will share their perspectives and latest accomplishments in pulmonary and nasal drug delivery. This international symposium also offers delegates the latest insights into issues facing the global inhalation community, and numerous business networking opportunities.

As part of their Diamond Sponsorship, Aptar Pharma will lead three interactive workshops dedicated to connected health. Entitled “The Future of Connected Medicines: Promise and Potential Pitfalls”, these sessions will take place on Wednesday, May 8 and will be presented by Sai Shankar Director, Business Development - Connected Devices at Aptar Pharma along with David Van Sickle, Co-founder and CEO at Propeller Health.

Reaffirming their respiratory expertise, Aptar Pharma will also present two scientific posters during RDD Europe 2019, co-presented by Dr. Gerallt Williams, Director Scientific Affairs, Aptar Pharma:
· “Human Factor studies for unit-dose nasal sprays – a case study”, copresented by G. Williams, B. Grosjean, D. Chopard, P. Schwartz, J. Cabiddu
· “Investigation of leachables from pMDIs containing HFA 152a”, co-presented by S. Sarrailh, A. Piquenot, O. Michelet, G. Williams.

In addition to co-organizing the conference, Aptar Pharma will showcase their extensive portfolio of MDIs, DPIs and BAIs, including the growing range of connected devices, at an interactive Exhibit Table. Available as either add-on or fully integrated, Aptar’s c-devices can deliver improved patient health outcomes through better adherence. Also, discover the portfolio of active packaging solutions from Aptar CSP Technologies, now part of the Aptar family, which can help optimize your drug product’s packaging environment.

As Platinum Sponsor, Aptar Pharma will be hosting the Gala Dinner at RDD Europe 2019, which will take place on Thursday May 9 at Sud Lisboa, located on the banks of the Tagus River in Lisbon. Gael Touya, President of Aptar Pharma, will be on hand to welcome guests to this much-anticipated event, which combines fine-cuisine, dancing and networking to cap off the conference.

Register now at for RDD Europe 2019 – a mustattend conference for companies involved in research, development, testing and marketing of medicines, as well as devices and services associated with pulmonary or nasal products.

About Aptar Pharma
Aptar Pharma is part of AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing, sealing and active packaging solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. Aptar uses insights, design, engineering and science to create innovative packaging technologies that build brand value for its customers, and, in turn, make a meaningful difference in the lives, looks, health and homes of people around the world. Aptar is headquartered in Crystal Lake, Illinois and has over 14,000 dedicated employees in 18 different countries. For more information, visit

Media Contact:
Aptar Pharma
Carolyn Penot
+33 1 39 17 20 38
phone +33 (0)13 917 2020
email 36-38 Rue de la Princesse, 78431 Louveciennes
Print this page
Send to a friend
News and Press Releases

3P Biopharmaceuticals welcomes Keensight Capital as majority shareholder

More info >>

White Papers

The Emerging Use of Social Media in Orphan Disease Drug Research

Worldwide Clinical Trials Ltd

The use of various social media platforms, such as Twitter, Instagram, Facebook, and LinkedIn, for dissemination of clinical trial information has created a cornucopia of possibilities enabling clinical trial performance. Characterized by a people-to-people immediacy, social media permits extraordinarily adaptive modification of study information in real-time, and it does so in a highly targeted fashion.
More info >>

Industry Events


28-30 April 2020, Javits Center NYC

More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement